You are here: Home » PTI Stories » National » News
Business Standard

Vivimed Labs to acquire Hungary-based Soneas

Press Trust of India  |  New Delhi 

Drug firm today said it has pacts to acquire Hungary-based contract development and firm for an undisclosed amount.

Spain S.L, the parent of S.A has signed definitive agreements to facilitate the acquisition of Soneas, said in a BSE filing.

"The acquisition broadens Uquifa's market offering in the contract development and organisation (CDMO) space by enhancing its ability to now undertake preclinical, phase I, II and III NCE project development," Vivimed Labs said.

Shares of Vivimed Labs today closed at Rs 67.80 per scrip on BSE, up 2.73 per cent from its previous close. PTI AKT.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, May 16 2018. 20:30 IST